Speakers

Simon joined Teenage Cancer Trust in 2000 as the charity's first full-time Chief Executive. He has managed the development and expansion of Teenage Cancer Trust’s units, services, education programme and professional training, fundraising, communications and infrastructure.

He has been instrumental in influencing NHS health policy to improve structures, facilities, treatment and care of teenagers and young adults with cancer.

In 2008 he was short listed for Entrepreneur of the Year 2008 and over the last nine years has overseen an increase in income from £1.5million to £9million.

Graduated in Chemistry before a brief period in battery research with Ever Ready. Held a wide variety of roles in a number of therapeutic areas with over 30 years experience in pharma with Merck Serono; he feels particularly privileged to have been involved in the launch of beta blockers into treatment for heart failure and the world’s most successful treatment for Type II diabetes. Appointed Head of Nurse Management in January 2010, he is responsible for the support services that optimise patients’ adherence and persistence to treatment.  

Mark Duman is a qualified pharmacist who has worked in a wide range of healthcare and related organisations.  Within the King’s Fund he founded Ask About Medicines and published ‘Producing Patient Information’.  In the BBC he delivered a range of initiatives to motivate people to improve their health and lifestyle.  

Following subsequent roles in publishing and telecoms, Mark is now an independent consultant focused on improving patient experience and outcomes through better communication.  Clients include AstraZeneca, Central Office of Information, Department of Health, Microsoft, NHS Direct, Novartis, Picker Europe, Scholl and Tunstall Group.  

He contributes to various public service and commercial Advisory and Editorial Boards.  Mark is a Non Executive Director of Luto research Ltd and President of the Patient Information Forum.

Mark is married with four children and lives happily in Manchester, England.

Michael Holden read pharmacy at Portsmouth School of Pharmacy. He was awarded a BScPharm in 1976 and did his pre-registration year with Boots and progressed through the company with a number of management appointments.

Michael established his own community pharmacy group in Hampshire between 1988 and 2002 and then worked with Pharmacy Alliance developing pharmacy services between 2003 and 2005.

Between 2005 and 2010 Michael was Chief Officer of the Hampshire and Isle of Wight Local Pharmaceutical Committee. During his time with the LPC, he actively led the expansion of community pharmacy services including the development of the Healthy Living Pharmacy initiative.

Michael was appointed Chief Executive of the National Pharmacy Association for the UK in January 2011 and represents the NPA and community pharmacy on a number of national fora.

Michael is married with three daughters and lives in Hampshire, England. He enjoys travel, cycling, golf, tennis, cooking and fine wine.

Keith Allan is currently Head of Global Product Advocacy for Novartis based in Basel, Switzerland. This position is aligned to the Market Access needs for Novartis products, and is involved in creating sustainable partnerships with influential stakeholders - particularly academic/scientific groups, KOLs, patient organisations and regulatory advisors. He joined Novartis in 2000 as Head of Global Respiratory Marketing.

He was previously Global Marketing Director for Aventis Respiratory and Allergy Portfolio (formerly Rhone-Poulenc Rorer), based their Corporate Headquarters in Paris, France.

Originally a Graduate Microbiologist/Biochemist, working in medical research, he started his pharmaceutical industry career with Hoechst as a Medical Representative in the UK, before moving to Fisons Pharmaceuticals also as a Medical Representative, Sales Trainer and Area Sales Manager. His marketing career started with Fisons as a Brand Manager for Intal in the UK before moving to Merck (MSD) where he was their UK Marketing Manager for 5 years, also involved in Business Development activities. He re-joined Fisons in 1986, where after a period in Global Strategic Marketing, he was appointed Marketing and Sales Director for Fisons France, for 3 years just prior the RPR acquisition of Fisons. Following the acquisition in 1995, he was appointed to Global Marketing Director, a position he held until after the merger with HMR to form Aventis in 1999.

Speaker bio coming soon...

Speaker bio coming soon...

Silja is the owner and CEO of whydot GmbH, an agency specialized in social media consulting, coaching and training. Her fields of expertise are the creation of patient-focused social media communications and marketing campaigns. Previously, Silja was a consultant and held senior positions in major pharmaceutical companies. She holds a BS in International Business and Marketing from Georgetown University in Wash. DC and an MBA from INSEAD. Silja speaks German, English and French.

Paul Wicks, PhD. is managing director of PatientsLikeMe UK, the British subsidiary of a healthcare company that builds online communities for patients with life-changing illnesses. The site empowers patients to share their health data in order to improve their outcomes and be a catalyst for research. In Paul’s previous role as Director of the R&D team, he was responsible for the medical architecture of PatientsLikeMe's online communities and conducting research to generate insights from the personal health data shared by patients. Since 2006 his team published over fifteen research studies including an innovative patient-lead trial of lithium in ALS, the development of novel patient-reported outcomes, and establishing the benefits of sharing health data online. Prior to joining PatientsLikeMe, Paul studied cognition in rare forms of ALS, and emotional changes in Parkinson’s disease at the Institute of Psychiatry, King’s College London. In 2011 Paul was awarded “Humanitarian of the Year” and named a TR35 by MIT’s Technology Review magazine.

Global Associate Brand Director in Critical Care Franchise of Novartis Global Brand Management Team. Key responsibilities include driving essentials of the strategy for launch preparedness & successful launch plans on PR Campaign & Execution Plan, SF Selling Modules, Train the Trainer programs & Digital Strategy.

15 years’ experience with Sales & Marketing with Eli Lilly & Company in different roles including International Marketing at Lilly HQ’s in Indianapolis, USA as well as Lilly India. Worked across different therapeutic area-Diabetes, Cardiovascular, Osteoporosis & Oncology.

Key areas of interest: e-marketing Strategy, Training & Sales Force effectiveness, Congress strategy, PR  & working with patient groups.

Dr. Natz is Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (www.eucope.org). He is also heading the Brussels Office of Bundesverband der Pharmazeutischen Industrie e.V. (BPI). Before, he has been a lawyer with Sträter Law Firm in Germany and also worked in the pharmaceutical industry. As a research assistant at Duke University (USA) he has dealt with international pharmaceutical law.

Speaker bio coming soon...

Lars Jonsson has operated in the pharmaceutical business for 24 years, holding various director roles across Communication, Public Affairs, and Advocacy.

He assumed the position of Head of Global Advocacy at Bayer HealthCare 3 years ago, heading a team of three people. Since undertaking the role, Lars has built up the Global Advocacy function, establishing objectives with a focus on market access; developing Advocacy plans across key business franchises; and generating policy resolutions at EU/DC levels with endorsement by critical professional organisations and policymakers.

Caroline Brocklehurst, CF Patient
Presentation title: Quantifying the value and of adherence initiatives

Tom Grew, University College London Hospital
Presentation title: Quantifying the value of adherence initiatives

Rachel Campsey, Clinical Research Nurse, Teenagers and Young Adults, The Christie Hospital
Presentation title: The nurse perspective

Deirdre  Brunton, TYA Lead Nurse, University Hospital Bristol
Presentation title: The nurse perspective

Dr. Hans in‘t Veen, Pulmonologist, St. Franciscus Hospital Rotterdam
Presentation title: Innovation in patient reported outcomes data

Carole North is co-founder of 90TEN Healthcare. She has over 11 years’ experience of delivering programmes that increase adherence to treatment by empowering patients to change their health beliefs and behaviours, supporting HCPs to manage those patients, and developing initiatives that help reduce acute hospital admissions. 90TEN Healthcare consistently wins awards for its adherence, concordance, experiential and social marketing campaigns, and is currently delivering patient adherence programmes in 23 countries.

Soon after her first breast cancer experience, she got actively involved with the cancer patient organizations in Greece and internationally, offering her professional services as a volunteer Board Member, as a Chair of standing committees, as a trainer, as a campaigner. She has been instrumental in developing a guide of social insurance & welfare benefits for cancer patients, training volunteers to answer patient questions on the help line and in setting the bases for a robust cancer patient rights advocacy program. Kathi is a graduate of Athens University, and a post-graduate of McGill University. She is fluent in Greek, English, French, German, Dutch. She likes jazz, films of Woody Allen, spends time gardening, she is an avid reader, and enjoys company of friends with a glass of wine.

Since May 2011, she is working as Manager Global Projects being responsible for the roll-out of patient-centric services internationally across Pharmexx which includes the development of service blueprints, workshop gearance, and the development of tailor-made solutions in this area. She has also held speeches on Health Management Services on several pharma conferences on international level.

Dr Michael Reilly has over 22 years experience in UK and global telecommunications with BT, O2, Worldcom, Deutsche Telecom and France Telecom - specifically strategy development, B2B data product development and business growth - including being Director for Orange Healthcare in the UK, with a remit to develop a strategy and set of wireless and application services that improve patient experience and the working lives of health professionals. His launch of two specific services into the NHS (Orange Smart Numbers and Orange Health Gateway contributed to Orange winning the Frost and Sullivan Award for Product Excellence in Healthcare 2010).

Dr Reilly is a frequent speaker at conferences including Telco 2.0, NHS Expo, Mobile Phama Summit, Bench to Boardroom and Mobile World Health Congress as well as a respected commentator in various media on issues relating to mobilising healthcare. His in depth understanding of mobile technology and real success in delivering successful services as well as his understanding of  the health and care value chain players (Network operators, device manufacturers,  private medical insurers, application developers, Pharma and Retail Pharmacy and integrators) makes him a highly regarded subject matter expert.

He is currently Director of mHealth for DORO AB, positioning their device and application portfolio (which targets the senior sector) as an open platform for mobilised health and disease management applications. Michael represents Doro as a member of the Continua EU Task Force on regulatory issues affecting medical applications on mobile devices.

Prior to joining Teva she held management positions in marketing and sales at Eli Lilly and Johnson & Johnson and headed her own business as a business development consultant. Overall, Lilac has over 12 years of experience in the pharmaceutical and medical devises businesses.